Next Article in Journal
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5–10-Year-Old Burkinabe Children Naturally Exposed to Malaria
Next Article in Special Issue
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Previous Article in Journal
Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency
Previous Article in Special Issue
Harnessing Immunity to Treat Advanced Thyroid Cancer
 
 
Review

Article Versions Notes

Vaccines 2024, 12(2), 165; https://doi.org/10.3390/vaccines12020165
Action Date Notes Link
article xml file uploaded 6 February 2024 07:41 CET Original file -
article xml uploaded. 6 February 2024 07:41 CET Update -
article pdf uploaded. 6 February 2024 07:41 CET Version of Record -
article html file updated 6 February 2024 07:43 CET Original file -
article xml file uploaded 6 February 2024 09:13 CET Update -
article xml uploaded. 6 February 2024 09:13 CET Update -
article pdf uploaded. 6 February 2024 09:13 CET Updated version of record -
article html file updated 6 February 2024 09:15 CET Update -
article html file updated 6 February 2024 09:16 CET Update -
article html file updated 6 February 2024 09:17 CET Update -
article xml file uploaded 6 February 2024 09:57 CET Update -
article xml uploaded. 6 February 2024 09:57 CET Update https://www.mdpi.com/2076-393X/12/2/165/xml
article pdf uploaded. 6 February 2024 09:57 CET Updated version of record https://www.mdpi.com/2076-393X/12/2/165/pdf
article html file updated 6 February 2024 09:58 CET Update https://www.mdpi.com/2076-393X/12/2/165/html
Back to TopTop